QWZ — Prognostic Test For Assessment Of Chronic Kidney Disease Progression Class II

FDA Device Classification

Classification Details

Product Code
QWZ
Device Class
Class II
Regulation Number
862.1223
Submission Type
Review Panel
CH
Medical Specialty
Clinical Chemistry
Implant
No

Definition

A prognostic test for assessment of chronic kidney disease progression is an in vitro diagnostic device intended to measure one or more analytes obtained from human samples as an aid in assessing the risk for progression of chronic kidney disease. This device is not intended for diagnosis of any disease, for serial monitoring of kidney disease progression, or for monitoring the effect of any therapeutic product.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
DEN200052renalytix aiKidneyIntelX.dkdJune 29, 2023